Two of our long time scientific advisors have been elected to the prestigious National Academy of Sciences, one of the highest honors bestowed upon research scientists.

Nathaniel Heintz, PhD
Nathaniel (Nat) Heintz is the James and Marilyn Simons Professor and head of the Laboratory of Molecular Biology at The Rockefeller University in New York. Dr. Heintz is also a Howard Hughes Medical Institute investigator. His interest and expertise lie in the development and functioning of the mammalian cerebellum.

Michael Kastan, MD, PhD
Michael (Mike) Kastan is Executive Director of the Duke Cancer Institute and the William and Jane Shingleton Professor of Pharmacology and Cancer Biology and Professor of Pediatrics at Duke University School of Medicine in North Carolina. Dr. Kastan’s laboratory has been, and continues to be, interested in how cells respond to DNA damage and other types of stress. Besides providing advice to us, Dr. Kastan’s teams over the years have made critical discoveries about the A-T protein.

Both Dr. Heintz and Dr. Kastan have served as trusted scientific advisors and friends to the A-TCP for many years, and we congratulate them both.

Oops! We could not locate your form.

Related News

May 14 @ 6:49 pm

Lost Cleveland Memories’ 500th Presentation for the A-TCP!

Dennis has turned his love of history and storytelling into Lost Cleveland Memories, an incredibly successful fundraising effort

more
May 14 @ 6:49 pm

Race with the A-T CureTeam at Disney!

Announcing the CureTeam's Walt Disney World race schedule!

more
May 14 @ 6:49 pm

Disappointing Results from Quince’s Clinical Trial of eDSP in A-T

Quince Therapeutics reports topline results from their Phase 3 “NEAT” trial in A-T.

more
May 14 @ 6:49 pm

Press Release about Intrabio’s A-T Trial Results

IntraBio announces positive trial results of Levacetylleucine for the treatment of ataxia-telangiectasia.

more